DNA Link, Inc. (KOSDAQ:127120)
South Korea
· Delayed Price · Currency is KRW 7,700.00
+440.00 (6.06%)
At close: Mar 26, 2025, 3:30 PM KST
DNA Link Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Operating Revenue | 15,908 | 21,949 | 16,981 | 22,992 | 15,286 | Upgrade
|
| Other Revenue | -0 | -0 | -0 | -0 | -0 | Upgrade
|
| Revenue | 15,908 | 21,949 | 16,981 | 22,992 | 15,286 | Upgrade
|
| Revenue Growth (YoY) | -27.52% | 29.26% | -26.14% | 50.41% | -1.84% | Upgrade
|
| Cost of Revenue | 13,195 | 16,479 | 13,872 | 16,754 | 13,011 | Upgrade
|
| Gross Profit | 2,713 | 5,469 | 3,109 | 6,238 | 2,275 | Upgrade
|
| Selling, General & Admin | 10,941 | 8,191 | 6,947 | 7,262 | 8,309 | Upgrade
|
| Research & Development | 18.9 | 84.63 | 465.02 | 538.94 | 463.83 | Upgrade
|
| Other Operating Expenses | 62.69 | 79.68 | 38.38 | 33.2 | 32.71 | Upgrade
|
| Operating Expenses | 11,812 | 9,704 | 8,440 | 12,158 | 8,279 | Upgrade
|
| Operating Income | -9,100 | -4,235 | -5,330 | -5,920 | -6,004 | Upgrade
|
| Interest Expense | -569.07 | -258.18 | -59.22 | -41.64 | -534.63 | Upgrade
|
| Interest & Investment Income | 475 | 290.55 | 437.24 | 349.31 | 136.88 | Upgrade
|
| Earnings From Equity Investments | -5,714 | 269.4 | -2,149 | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | 80.19 | -32.13 | 409.71 | 477.81 | -285.64 | Upgrade
|
| Other Non Operating Income (Expenses) | 1,413 | 86.69 | -19.12 | 37.22 | -3,178 | Upgrade
|
| EBT Excluding Unusual Items | -13,414 | -3,878 | -6,711 | -5,097 | -9,866 | Upgrade
|
| Gain (Loss) on Sale of Investments | 1,936 | -433.3 | 220.16 | -229.32 | -1,442 | Upgrade
|
| Gain (Loss) on Sale of Assets | 676.26 | -2.2 | -0.83 | 4.66 | 37.04 | Upgrade
|
| Asset Writedown | - | -1,282 | -1,585 | -869.16 | -3,019 | Upgrade
|
| Other Unusual Items | - | - | - | - | 517.14 | Upgrade
|
| Pretax Income | -10,802 | -5,596 | -8,077 | -6,191 | -13,773 | Upgrade
|
| Income Tax Expense | - | - | 0.99 | - | - | Upgrade
|
| Earnings From Continuing Operations | -10,802 | -5,596 | -8,078 | -6,191 | -13,773 | Upgrade
|
| Minority Interest in Earnings | - | - | 296.2 | 1,091 | 705.69 | Upgrade
|
| Net Income | -10,802 | -5,596 | -7,782 | -5,100 | -13,067 | Upgrade
|
| Net Income to Common | -10,802 | -5,596 | -7,782 | -5,100 | -13,067 | Upgrade
|
| Shares Outstanding (Basic) | 20 | 17 | 17 | 16 | 13 | Upgrade
|
| Shares Outstanding (Diluted) | 20 | 17 | 17 | 16 | 13 | Upgrade
|
| Shares Change (YoY) | 15.03% | 2.41% | 3.19% | 26.11% | 14.09% | Upgrade
|
| EPS (Basic) | -542.00 | -323.00 | -459.99 | -311.09 | -1005.20 | Upgrade
|
| EPS (Diluted) | -542.00 | -323.00 | -460.00 | -311.09 | -1005.20 | Upgrade
|
| Free Cash Flow | -23,497 | -7,906 | -4,021 | -10,449 | -248.74 | Upgrade
|
| Free Cash Flow Per Share | -1179.02 | -456.31 | -237.71 | -637.36 | -19.13 | Upgrade
|
| Gross Margin | 17.05% | 24.92% | 18.31% | 27.13% | 14.88% | Upgrade
|
| Operating Margin | -57.20% | -19.29% | -31.39% | -25.75% | -39.28% | Upgrade
|
| Profit Margin | -67.90% | -25.50% | -45.82% | -22.18% | -85.48% | Upgrade
|
| Free Cash Flow Margin | -147.71% | -36.02% | -23.68% | -45.45% | -1.63% | Upgrade
|
| EBITDA | -7,467 | -2,707 | -3,438 | -4,230 | -3,867 | Upgrade
|
| EBITDA Margin | -46.94% | -12.33% | -20.25% | -18.40% | -25.30% | Upgrade
|
| D&A For EBITDA | 1,632 | 1,527 | 1,892 | 1,690 | 2,137 | Upgrade
|
| EBIT | -9,100 | -4,235 | -5,330 | -5,920 | -6,004 | Upgrade
|
| EBIT Margin | -57.20% | -19.29% | -31.39% | -25.75% | -39.28% | Upgrade
|
| Advertising Expenses | 262.43 | 217.54 | 251.49 | 89.43 | 143.88 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.